Research Article - (2012) Volume 3, Issue 2

Omalizumab: Anti-IgE Therapy in Severe Allergic Conditions

Arzu Didem Yalcin1* and Atil Bisgin2
1Department of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey, E-mail: abisgin@yahoo.com
2Department of Medical Genetics, Antalya, Turkey, E-mail: abisgin@yahoo.com
*Corresponding Author: